Wall Street Journal -
8 Dec 2021 14:41

Pfizer and BioNTech said that a third dose of their Covid-19 vaccine neutralized the Omicron variant in lab tests but that the two-dose regimen was significantly less effective at blocking the virus.
Share this Article